XFOR Gross Profit from 2010 to 2024

XFOR Stock  USD 0.90  0.03  3.19%   
X4 Pharmaceuticals Gross Profit yearly trend continues to be relatively stable with very little volatility. Gross Profit is likely to grow to about -1.9 M this year. Gross Profit is the profit X4 Pharmaceuticals makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2010-12-31
Previous Quarter
-2 M
Current Value
-1.9 M
Quarterly Volatility
1.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check X4 Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XFOR main balance sheet or income statement drivers, such as Interest Income of 3.5 M, Depreciation And Amortization of 3.6 M or Interest Expense of 3 M, as well as many exotic indicators such as Price To Sales Ratio of 40.66, Dividend Yield of 0.0 or PTB Ratio of 3.06. XFOR financial statements analysis is a perfect complement when working with X4 Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement X4 Pharmaceuticals' financial leverage analysis and stock options assessment as well as various X4 Pharmaceuticals Technical models . Check out the analysis of X4 Pharmaceuticals Correlation against competitors.
To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.

Latest X4 Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of X4 Pharmaceuticals over the last few years. Gross profit is a required income statement account that reflects total revenue of X4 Pharmaceuticals minus its cost of goods sold. It is profit before X4 Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. X4 Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in X4 Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported M10 Years Trend
Slightly volatile
   Gross Profit   
       Timeline  

XFOR Gross Profit Regression Statistics

Arithmetic Mean(130,013)
Geometric Mean0.00
Coefficient Of Variation(1,243)
Mean Deviation1,040,018
Median0.00
Standard Deviation1,616,507
Sample Variance2.6T
Range5.5M
R-Value(0.31)
Mean Square Error2.5T
R-Squared0.1
Significance0.26
Slope(112,969)
Total Sum of Squares36.6T

XFOR Gross Profit History

2024-1.9 M
2023-2 M
2022-2 M
2021-1.9 M
2020M
2019-672 K
20183.5 M

Other Fundumenentals of X4 Pharmaceuticals

X4 Pharmaceuticals Gross Profit component correlations

0.940.35-0.91-0.780.75-0.410.390.99-0.620.630.840.81-0.920.520.910.820.80.710.56-0.65-0.32
0.940.46-0.96-0.620.56-0.180.070.94-0.70.440.720.61-0.940.530.770.630.720.580.36-0.45-0.21
0.350.46-0.5-0.230.25-0.07-0.220.43-0.170.220.00.08-0.410.020.040.060.060.060.17-0.13-0.21
-0.91-0.96-0.50.55-0.530.1-0.07-0.930.56-0.44-0.69-0.50.84-0.32-0.69-0.57-0.72-0.67-0.360.420.15
-0.78-0.62-0.230.55-0.980.64-0.65-0.780.43-0.94-0.7-0.880.74-0.32-0.74-0.87-0.52-0.51-0.910.930.72
0.750.560.25-0.53-0.98-0.710.710.75-0.320.970.720.85-0.650.240.710.830.560.590.95-0.92-0.75
-0.41-0.18-0.070.10.64-0.71-0.76-0.370.09-0.61-0.61-0.710.23-0.43-0.58-0.62-0.51-0.48-0.620.70.56
0.390.07-0.22-0.07-0.650.71-0.760.370.090.670.540.75-0.160.10.610.730.410.550.7-0.72-0.38
0.990.940.43-0.93-0.780.75-0.370.37-0.590.650.80.78-0.910.430.870.810.770.710.58-0.65-0.33
-0.62-0.7-0.170.560.43-0.320.090.09-0.59-0.32-0.5-0.510.67-0.44-0.56-0.41-0.46-0.28-0.260.260.26
0.630.440.22-0.44-0.940.97-0.610.670.65-0.320.610.76-0.530.020.560.730.440.530.99-0.88-0.83
0.840.720.0-0.69-0.70.72-0.610.540.8-0.50.610.77-0.650.480.890.750.960.880.58-0.63-0.45
0.810.610.08-0.5-0.880.85-0.710.750.78-0.510.760.77-0.710.520.910.940.630.570.73-0.82-0.48
-0.92-0.94-0.410.840.74-0.650.23-0.16-0.910.67-0.53-0.65-0.71-0.61-0.78-0.72-0.57-0.4-0.450.570.29
0.520.530.02-0.32-0.320.24-0.430.10.43-0.440.020.480.52-0.610.630.50.420.1-0.04-0.30.06
0.910.770.04-0.69-0.740.71-0.580.610.87-0.560.560.890.91-0.780.630.90.830.730.52-0.67-0.24
0.820.630.06-0.57-0.870.83-0.620.730.81-0.410.730.750.94-0.720.50.90.610.590.7-0.9-0.36
0.80.720.06-0.72-0.520.56-0.510.410.77-0.460.440.960.63-0.570.420.830.610.920.41-0.44-0.28
0.710.580.06-0.67-0.510.59-0.480.550.71-0.280.530.880.57-0.40.10.730.590.920.52-0.49-0.3
0.560.360.17-0.36-0.910.95-0.620.70.58-0.260.990.580.73-0.45-0.040.520.70.410.52-0.87-0.84
-0.65-0.45-0.130.420.93-0.920.7-0.72-0.650.26-0.88-0.63-0.820.57-0.3-0.67-0.9-0.44-0.49-0.870.63
-0.32-0.21-0.210.150.72-0.750.56-0.38-0.330.26-0.83-0.45-0.480.290.06-0.24-0.36-0.28-0.3-0.840.63
Click cells to compare fundamentals

About X4 Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include X4 Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. X4 Pharmaceuticals investors use historical funamental indicators, such as X4 Pharmaceuticals's Gross Profit, to determine how well the company is positioned to perform in the future. Although X4 Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in X4 Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on X4 Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on X4 Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in X4 Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Gross Profit-2 M-1.9 M
Gross Profit Margin 0.00  0.00 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether X4 Pharmaceuticals is a strong investment it is important to analyze X4 Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact X4 Pharmaceuticals' future performance. For an informed investment choice regarding XFOR Stock, refer to the following important reports:
Check out the analysis of X4 Pharmaceuticals Correlation against competitors.
To learn how to invest in XFOR Stock, please use our How to Invest in X4 Pharmaceuticals guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for XFOR Stock analysis

When running X4 Pharmaceuticals' price analysis, check to measure X4 Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy X4 Pharmaceuticals is operating at the current time. Most of X4 Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of X4 Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move X4 Pharmaceuticals' price. Additionally, you may evaluate how the addition of X4 Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world
Is X4 Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of X4 Pharmaceuticals. If investors know XFOR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about X4 Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.67)
Return On Assets
(0.61)
Return On Equity
(4.89)
The market value of X4 Pharmaceuticals is measured differently than its book value, which is the value of XFOR that is recorded on the company's balance sheet. Investors also form their own opinion of X4 Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is X4 Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because X4 Pharmaceuticals' market value can be influenced by many factors that don't directly affect X4 Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between X4 Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if X4 Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, X4 Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.